Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers for Prediction of Analgesic Efficacy Based on Interrelations Between Pain Modulation and EEG vs. Drugs' Mode of Action in Knee OA

NCT05256342 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT05256342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05256342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers for Prediction of Analgesic Efficacy Based on Interrelations Between Pain Modulation and EEG vs. Drugs' Mode of Action in Knee OA
Lead sponsor
Rambam Health Care Campus
Phase
Not applicable
Overall status
Completed
Start date
December 30, 2021
Completion date
April 8, 2024
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers for prediction of oa treatment efficacy, knee, osteoarthritis (oa)